3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
3
Neoplasms
2
Fallopian Tube Neoplasms
2
Stomach Neoplasms
1
Ovarian Neoplasms
1
Microsatellite Instability
1
Lymphedema
1
Lung Neoplasms
1
Hematopoietic Cell Transplantation Recipient
1
Gastritis, Atrophic
1
Endometrial Neoplasms
1
Depression
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colorectal Neoplasms
1
Cancer Awareness and Prevention Education
1
Brenner Tumor
1
Breast Carcinoma In Situ
1
Anxiety Disorders
1
Interventions
Paclitaxel
6
Carboplatin
6
Radiotherapy
5
olaparib
4
Surveys and Questionnaires
4
Cisplatin
4
Surgical Procedures, Operative
3
Sentinel Lymph Node Biopsy
3
Metformin
3
pembrolizumab
2
lenvatinib
2
durvalumab
2
dostarlimab
2
anlotinib
2
Reverse Transcriptase Polymerase Chain Reaction
2
Progesterone
2
Magnetic Resonance Spectroscopy
2
Injections
2
High-Energy Shock Waves
2
Hematologic Tests
2
Genetic Testing
2
Docetaxel
2
Blood Specimen Collection
2
Base Sequence
2
Amplified Fragment Length Polymorphism Analysis
2
vistusertib
1
serabelisib
1
pazopanib
1
palbociclib
1
onapristone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Endometrial Neoplasms
×
Educational Status
×
Clear all
NCT01853865
2017-11-06
OPAL
Odense University Hospital
Phase NA
Unknown
211 enrolled